342 results on '"Livadas, Sarantis"'
Search Results
102. Erratum to: Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome
103. Control of the onset of puberty
104. Levothyroxine replacement therapy: once treatment is started, should it last indefinitely?
105. Significant effect of a group education program on glycemic control and incidence of hypoglycemia in patients with diabetes mellitus type 1: A case-controlled study
106. Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial
107. Does visceral adiposity index signify early metabolic risk in children and adolescents?: Association with insulin resistance, adipokines, and subclinical inflammation
108. Control of the onset of puberty
109. Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances
110. Beta-Thalassemia Major and Female Fertility: The Role of Iron and Iron-Induced Oxidative Stress
111. Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats
112. Severe hyperinsulinemia, decreased GLUT3 and GLUT4 expression, and increased retinol binding protein 4 in a patient with chronic graft-versus-host disease post bone marrow transplantation
113. Endocrine and metabolic aspects of the Wolfram syndrome
114. A low glycaemic index, low glycaemic load snack based on stevia and fortified with vitamin D, improves metabolic/hormonal profile, and compliance in normal subjects and prediabetics; results from a 4 months, controlled trial
115. The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome
116. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia
117. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome
118. PROP1 gene mutations and pituitary size: A unique case of two consecutive cycles of enlargement and regression
119. Thyroid volume and echostructure in schoolchildren living in an iodine-replete area: Relation to age, pubertal stage, and body mass index
120. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome
121. Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome
122. Does visceral adiposity index signify early metabolic risk in children and adolescents?: Association with insulin resistance, adipokines, and subclinical inflammation
123. Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats
124. Association of advanced glycosylation end products receptor polymorphisms with coronary heart disease in postmenopausal women
125. White blood cells levels and PCOS: direct and indirect relationship with insulin resistance, but not with hyperandogenemia
126. Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances
127. Strong and positive association of Endothelin-1 with AGEs in PCOS: A causal relationship or a bystander?
128. Severe hyperinsulinemia, decreased GLUT3 and GLUT4 expression, and increased retinol binding protein 4 in a patient with chronic graft-versus-host disease post bone marrow transplantation
129. Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS
130. Erratum to: Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome
131. Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome
132. Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome
133. Hyperreninemia Characterizing Women with Polycystic Ovary Syndrome Improves after Metformin Therapy
134. A Favorable Metabolic and Antiatherogenic Profile in Carriers of CYP21A2 Gene Mutations Supports the Theory of a Survival Advantage in This Population
135. Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
136. Thyroid Volume and Echostructure in Schoolchildren Living in an Iodine-Replete Area: Relation to Age, Pubertal Stage, and Body Mass Index
137. Glucose Dysregulation in Obese Children: Predictive, Risk, and Potential Protective Factors*
138. PROP1 Gene Mutations and Pituitary Size: A Unique Case of Two Consecutive Cycles of Enlargement and Regression
139. Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial.
140. Disappearance of a growth hormone secreting macro adenoma during long-term somatostatin analogue administration and recurrence following somatostatin withdrawal
141. Spontaneous pregnancy and birth of a normal female from a woman with Turner syndrome and elevated gonadotropins
142. Gonadoblastoma in a patient with del(9)(p22) and sex reversal
143. Assessment of Thyroid Function in Two Hundred Patients withβ-Thalassemia Major
144. Polycystic Ovary Syndrome: Definitions, Phenotypes and Diagnostic Approach.
145. Assessment of Thyroid Function in Two Hundred Patients with β-Thalassemia Major.
146. Does visceral adiposity index signify early metabolic risk in children and adolescents?: Association with insulin resistance, adipokines, and subclinical inflammation
147. The Relationship between Resting Metabolic Rate and Body Composition in People Living with Overweight and Obesity.
148. A Favorable Metabolic and Antiatherogenic Profile in Carriers of CYP21A2Gene Mutations Supports the Theory of a Survival Advantage in This Population
149. Secondary Cardiovascular Disease Prevention Deficit Persists over the Years: A Multicenter Cross-Sectional Study Involving 1003 Consecutive Patients from Greece.
150. Long-Term Effects of 0.1 mg Recombinant-Human-Thyrotropin-Stimulated Fixed-Dose Radioiodine Therapy in Patients with Recurrent Multinodular Goiter after Surgery.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.